MediPharm Labs’ family of branded products deliver high-quality, innovative cannabis concentrate-based products for daily use, to consumers and patients across Canada.
With our sophisticated, pharmaceutical-quality GMP certified platform and R&D capabilities, we have the ability to create best-in-class products, with the formulations, potency, and purity to meet current needs and evolving consumer trends. MediPharm Labs’ new line of medical products are available to patients and consumers in Canada. The line includes a CBD25 Regular Formula, a CBD50 Plus Formula and a CBD25:5 Release Formula:
MediPharm Labs CBD25 Regular Formula
Product Category: High-CBD, Low-THC (25mg of CBD per mL to 1mg of THC per mL) 500mg of Total CBD per 20mL bottle
MediPharm Labs CBD25 is a pharma-quality CBD dominant Regular Strength oil containing 25 mg/mL of CBD using full spectrum cannabis concentrate processed at MediPharm Labs’ GMP certified facility under strict manufacturing standards producing a product with exceptional quality and purity.
MediPharm Labs CBD50 Plus Formula Oil CBD
Product Category: Very High-CBD 50:2 (50mg of CBD per mL to 2mg of THC per mL) 1000mg of Total CBD per 20mL bottle
MediPharm Labs CBD50 is a pharma-quality high-CBD Plus Formula oil containing our highest amount of CBD (50 mg/mL) using full spectrum cannabis concentrate produced at MediPharm Labs’ GMP certified facility under strict manufacturing standards producing a product with exceptional quality and purity.
MediPharm Labs CBD25:5 Release Formula
Product Category: High-CBD 25:5 CBD (25mg of CBD per mL to 5mg of THC per mL) 500mg Total CBD and 200mg Total THC per 20 mL bottle
MediPharm Labs CBD25:5 is a pharma-quality CBD dominant Release Formula oil containing 25 mg/mL of CBD using full spectrum cannabis concentrate produced at MediPharm Labs’ GMP certified facility under strict manufacturing standards producing a product with exceptional quality and purity. MediPharm Labs has formulated a diverse ‘Release Formula’ which is dominated by CBD but also offers a ratio of THC since they are both known to work through different pharmacological mechanisms in the human body1.
All of our high-quality formulated oils have a unique flavour profile from the naturally occurring cannabis terpenes. The coconut/palm-based MCT carrier oil has been carefully chosen for its sustainable practices from plantation through manufacturing.
Visit us at www.medipharmlabs.com to learn more about these products and where you can find them.
About MediPharm Labs
MediPharm Labs has invested in an expert, research-driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities with five primary extraction lines for delivery of pure, trusted, and precision-dosed cannabis products for its customers. Through its wholesale and white label platforms, they formulate, consumer-test, process, package and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. As a global leader, MediPharm Labs has completed commercial exports to Australia and is nearing commercialization of its Australian extraction facility. MediPharm Labs Australia was established in 2017.
1The Diverse CB1 and CB2 Receptor Pharmacology of Three Plant Cannabinoids: delta9-tetrahydrocannabinol, Cannabidiol and delta9-tetrahydrocannabivarin https://pubmed.ncbi.nlm.nih.gov/17828291/